Rankings · Capital
Share count shrinking fastest
Graded A or B, ranked by how far the number of shares fell over three years. A buyback only shows here when it retires more shares than the company issues.
65 companies meet this test
Figures as of November 15, 2026
| # | Company | Grade | Share count, 3 years | Free cash flow yield | Market value |
|---|---|---|---|---|---|
| 1 | AZTAAZENTA, INC. | B- | -41.5% | 1.4% | $2B |
| 2 | THCTENET HEALTHCARE CORP | A+ | -28.0% | 14.6% | $22.8B |
| 3 | EXELEXELIXIS, INC. | A+ | -24.8% | 6.9% | $16.8B |
| 4 | UHSUNIVERSAL HEALTH SERVICES, INC. | B | -19.9% | 9.7% | $11.5B |
| 5 | HALOHALOZYME THERAPEUTICS, INC. | A+ | -18.9% | 7.7% | $11.4B |
| 6 | MCKMcKESSON CORPORATION | A | -18.8% | 5.6% | $127.3B |
| 7 | AMPHAmphastar Pharmaceuticals, Inc. | B+ | -18.6% | 11.1% | $1.3B |
| 8 | DOCSDoximity, Inc. | B+ | -16.4% | 5.5% | $5.9B |
| 9 | CIThe Cigna Group | A | -15.8% | — | $78.3B |
| 10 | PCRXPACIRA BIOSCIENCES, INC. | B | -13.8% | 11.6% | $1.5B |
More rankings
A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.